Does TAFAMIDIS Cause Hypervolaemia? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Hypervolaemia have been filed in association with TAFAMIDIS (Vyndamax). This represents 0.3% of all adverse event reports for TAFAMIDIS.
25
Reports of Hypervolaemia with TAFAMIDIS
0.3%
of all TAFAMIDIS reports
4
Deaths
12
Hospitalizations
How Dangerous Is Hypervolaemia From TAFAMIDIS?
Of the 25 reports, 4 (16.0%) resulted in death, 12 (48.0%) required hospitalization.
Is Hypervolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TAFAMIDIS. However, 25 reports have been filed with the FAERS database.
What Other Side Effects Does TAFAMIDIS Cause?
Death (2,553)
Dyspnoea (608)
Off label use (571)
Cardiac failure (444)
Fatigue (438)
Fall (372)
Malaise (301)
Hypoacusis (298)
Atrial fibrillation (296)
Asthenia (256)
What Other Drugs Cause Hypervolaemia?
TREPROSTINIL (580)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (428)
AMBRISENTAN (205)
MACITENTAN (202)
FUROSEMIDE (139)
AMLODIPINE (122)
CYCLOPHOSPHAMIDE (118)
SACUBITRIL\VALSARTAN (115)
TACROLIMUS (100)
PREDNISONE (98)
Which TAFAMIDIS Alternatives Have Lower Hypervolaemia Risk?
TAFAMIDIS vs TAFAMIDIS MEGLUMINE
TAFAMIDIS vs TAFASITAMAB
TAFAMIDIS vs TAFASITAMAB-CXIX
TAFAMIDIS vs TAFINLAR
TAFAMIDIS vs TAFLUPROST